291 results on '"N. Obara"'
Search Results
2. In-situ bypass is associated with superior infection-free survival compared with extra-anatomic bypass for the management of secondary aortic graft infections without enteric involvement
- Author
-
Janko, M.R. Hubbard, G. Back, M. Shah, S.K. Pomozi, E. Szeberin, Z. DeMartino, R. Wang, L.J. Crofts, S. Belkin, M. Davila, V.J. Lemmon, G.W. Wang, S.K. Czerny, M. Kreibich, M. Humphries, M.D. Shutze, W. Joh, J.H. Cho, S. Behrendt, C.-A. Setacci, C. Hacker, R.I. Sobreira, M.L. Yoshida, W.B. D'Oria, M. Lepidi, S. Chiesa, R. Kahlberg, A. Go, M.R. Rizzo, A.N. Black, J.H. Magee, G.A. Elsayed, R. Baril, D.T. Beck, A.W. McFarland, G.E. Gavali, H. Wanhainen, A. Kashyap, V.S. Stoecker, J.B. Wang, G.J. Zhou, W. Fujimura, N. Obara, H. Wishy, A.M. Bose, S. Smeds, M. Liang, P. Schermerhorn, M. Conrad, M.F. Hsu, J.H. Patel, R. Lee, J.T. Liapis, C.D. Moulakakis, K.G. Farber, M.A. Motta, F. Ricco, J.-B. Bath, J. Coselli, J.S. Aziz, F. Coleman, D.M. Davis, F.M. Fatima, J. Irshad, A. Shalhub, S. Kakkos, S. Zhang, Q. Lawrence, P.F. Woo, K. Chung, J.
- Abstract
Objective: The optimal revascularization modality following complete resection of aortic graft infection (AGI) without enteric involvement remains unclear. The purpose of this investigation is to determine the revascularization approach associated with the lowest morbidity and mortality using real-world data in patients undergoing complete excision of AGI. Methods: A retrospective, multi-institutional study of AGI from 2002 to 2014 was performed using a standardized database. Baseline demographics, comorbidities, and perioperative variables were recorded. The primary outcome was infection-free survival. Descriptive statistics, Kaplan-Meier survival analysis, and univariate and multivariable analyses were performed. Results: A total of 241 patients at 34 institutions from seven countries presented with AGI during the study period (median age, 68 years; 75% male). The initial aortic procedures that resulted in AGI were 172 surgical grafts (71%), 66 endografts (27%), and three unknown (2%). Of the patients, 172 (71%) underwent complete excision of infected aortic graft material followed by in situ (in-line) bypass (ISB), including antibiotic-treated prosthetic graft (35%), autogenous femoral vein (neo-aortoiliac surgery) (24%), and cryopreserved allograft (41%). Sixty-nine patients (29%) underwent extra-anatomic bypass (EAB). Overall median Kaplan-Meier estimated survival was 5.8 years. Perioperative mortality was 16%. When stratified by ISB vs EAB, there was a significant difference in Kaplan-Meier estimated infection-free survival (2910 days; interquartile range, 391-3771 days vs 180 days; interquartile range, 27-3750 days; P < .001). There were otherwise no significant differences in presentation, comorbidities, or perioperative variables. Multivariable Cox regression showed lower infection-free survival among patients with EAB (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.6-3.6; P < .001), polymicrobial infection (HR, 2.2; 95% CI, 1.4-3.5; P = .001), methicillin-resistant Staphylococcus aureus infection (HR, 1.7; 95% CI, 1.1-2.7; P = .02), as well as the protective effect of omental/muscle flap coverage (HR, 0.59; 95% CI, 0.37-0.92; P = .02). Conclusions: After complete resection of AGI, perioperative mortality is 16% and median overall survival is 5.8 years. EAB is associated with nearly a two and one-half-fold higher reinfection/mortality compared with ISB. Omental and/or muscle flap coverage of the repair appear protective. © 2022 Society for Vascular Surgery
- Published
- 2022
3. PS1115 THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY
- Author
-
K. Hosokawa, S. Chiba, Y. Kanakura, H. Takamori, J. Nishimura, T. Matsuda, H. Takahashi, Y. Ueda, K. Ando, S. Nakao, Y. Shirasugi, T. Kawaguchi, H. Ninomiya, H. Noji, N. Obara, Y. Yonemura, T. Shichishima, K. Ishiyama, and T. Ikezoe
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Bone Marrow failure syndromes ,Internal medicine ,Clone (cell biology) ,Clinical course ,Medicine ,In patient ,Hematology ,Prospective cohort study ,business ,Interim analysis - Published
- 2019
4. PS1308 TARGETING T-CELL RECEPTOR SIGNALING PATHWAY BY DASATINIB IN RELAPSED/REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
- Author
-
H. Momose, K. Ishitsuka, M. Sakata-Yanagimoto, Y. Kiyoki, N. Kurita, Y. Sato, T.B. Nguyen, M. Kusakabe, T. Suyama, S. Ogawa, S. Chiba, M. Fujisawa, A. Shinagawa, Takayasu Kato, H. Nishikii, N. Obara, Yasuhisa Yokoyama, Y. Nannya, S. Sukegawa, and Yuichi Hasegawa
- Subjects
Dasatinib ,Angioimmunoblastic T-cell lymphoma ,business.industry ,Relapsed refractory ,medicine ,Cancer research ,T Cell Receptor Signaling Pathway ,Hematology ,medicine.disease ,business ,medicine.drug - Published
- 2019
5. Cell signalling
- Author
-
K. Tsuchiya, S. Shiohira, H. Sugiura, M. Suzuki, K. Okano, K. Nitta, N. Kaesler, S. Immendorf, C. Ouyang, P. Carmeliet, J. Floege, T. Kruger, G. Schlieper, A. Georgescu, J. Kalucka, S. Olbrich, J. Baumgartl, T. Hackenbeck, K.-U. Eckardt, A. Weidemann, S. Chmielewski, A. Olejnik, K. Sikorski, U. Heemann, J. Wesoly, H. Bluyssen, M. Baumann, D. Mekahli, J.-P. Decuypere, L. Missiaen, E. Levtchenko, H. De Smedt, A. Stasi, G. Castellano, M. Gigante, A. Intini, P. Pontrelli, C. Divella, C. Curci, G. Grandaliano, L. Gesualdo, D. Vizza, A. Perri, D. Lofaro, P. Toteda, S. Lupinacci, F. Leone, P. Gigliotti, T. Papalia, R. Bonofiglio, A. V. Vatazin, P. V. Astakhov, A. B. Zulkarnaev, E. Parodi, D. Verzola, E. D'Amato, F. Viazzi, A. Gonnella, D. Garneri, R. Pontremoli, G. Garibotto, T.-H. Chen, C.-H. Chen, Y.-C. Chen, Y.-M. Sue, C.-Y. Cheng, L. Guiying, L. Ying, S. Pozzoli, M. Lino, S. Delli Carpini, M. Ferrandi, G. Zerbini, M. Simonini, L. Zagato, I. Molinari, L. Citterio, P. Manunta, X. Feng, X. Pan, W. Wang, N. Chen, Y.-x. Chen, W.-M. Wang, S. Tanaka, S. Yano, T. Sugimoto, H. Noh, M. R. Yu, H. J. Kim, S. A. Woo, Y. J. Cho, S. H. Kwon, J. S. Jeon, D. C. Han, H. Shimizu, M. Yisireyili, F. Nishijima, T. Niwa, E. S. Koh, S. Chung, S. J. Kim, H. E. Yoon, C. W. Park, Y. S. Chang, S. J. Shin, E. Y. Seong, H. Rhee, M. J. Shin, B. Y. Yang, Y. S. Jung, D. W. Lee, S. B. Lee, I. S. Kwak, I. Y. Kim, S. M. Sancho-Martinez, L. Prieto-Garcia, F. J. Lopez-Hernandez, J. M. Lopez-Novoa, E. H. Bae, H. S. Choi, S. Y. Joo, I. J. Kim, C. S. Kim, J. S. Choi, S. K. Ma, J. Lee, S. W. Kim, B. Humanes, C. Sonia, J. Jado, M. Mojena, J. Lara, L. Alvarez-Sala, A. Tejedor, A. Lazaro, Y. Wada, M. Iyoda, K. Matsumoto, Y. Shindo-Hirai, Y. Kuno, Y. Yamamoto, T. Suzuki, T. Shibata, T. Akizawa, S. Faubel, C. L. Edelstein, J. L. Cano Penalver, S. de Frutos Garcia, M. Griera Merino, A. Luengo Rodriguez, A. Garcia Jerez, L. Bohorquez Magro, D. Medrano, L. Calleros Basilio, M. Rodriguez Puyol, F. Thilo, Y. Liu, M. Tepel, H.-H. Hsu, K.-H. Chen, C.-C. Hung, C.-W. Yang, N. Endlich, J.-L. Lin, H. Pavenstadt, R. R. Rodrigues Diez, S. Mezzano, M. Ruiz-Ortega, R. Rodrigues Diez, C. Lavoz, Y. Nakayama, K. Fukami, S.-i. Yamagishi, N. Obara, M. Yokoro, R. Ando, Y. Kaida, M. Toyonaga, K. Kaifu, M. Takeuchi, S. Ueda, S. Okuda, K. Daenen, M. F. Hoylaerts, B. Bammens, J. Liu, F. Zhong, Q. Dai, L. Xu, A. Zaravinos, and C. C. Deltas
- Subjects
Transplantation ,Nephrology - Published
- 2013
6. Peritoneal dialysis
- Author
-
J. Liu, Y. Liu, Y. Xu, X. Zhao, J. Qian, B. Sun, C. Xing, R. Kanda, C. Hamada, T. Nakano, K. Wakabayashi, H. Io, S. Horikoshi, Y. Tomino, N. Ishimatsu, T. Miyamoto, H. Morimoto, J. Nakamata, R. Baba, K. Kanegae, R. Serino, N. Kabashima, Y. Otsuji, Y. Doi, M. Tamura, T. Kusumoto, K. Fukami, S.-I. Yamagishi, S. Ueda, Y. Kaida, T. Hazama, Y. Nakayama, R. Ando, N. Obara, S. Okuda, M. Matsumoto, Y. Furuno, H. Bang-Gee, L. Mazzotta, A. Rosati, A. Carlini, V. T. Henriques, E. Zangiacomi Martinez, J. C. Divino-Filho, R. Pecoits-Filho, J. A. Cardeal Da Costa, T. Gama Axelsson, B. Lindholm, J. J. Carrero, O. Heimburger, P. Stenvinkel, A. R. Qureshi, M. Akazawa, T. Uno, E. Kanda, Y. Maeda, M. Aktsiali, S. Antonopoulou, K. Tsiolaki, N. Bakirtzi, A. Patrinou, M. Georgopoulou, P. Liaveri, N. Afentakis, G. Tsirpanlis, T. Hasegawa, H. Nishiwaki, M. Hirose, D. Komukai, H. Tayama, F. Koiwa, A. Yoshimura, S. L. Lui, S. Lui, S. Yung, C. Tang, F. Ng, W. K. Lo, T. M. Chan, H. M. Koo, F. M. Doh, D. E. Yoo, H. J. Oh, T.-H. Yoo, K. H. Choi, S.-W. Kang, D. S. Han, S. H. Han, N. Fernandes, M. G. Bastos, M. R. Gianotti Franco, A. Chaoubah, M. D. Gloria Lima, S. Kang, J. Do, K. Cho, J. Park, K. Yoon, J.-B. Chen, B.-C. Cheng, T.-C. Chen, Y.-J. Su, C.-H. Wu, Y. Park, J. Jeon, M. Tsikeloudi, P. Pateinakis, K. Patsatsi, E. Manou, D. Sotiriadis, D. Tsakiris, L. Teixeira, A. Rodrigues, M. J. Carvalho, A. Cabrita, D. Mendonca, M. Bruschi, G. Candiano, L. Santucci, S. Luzio, R. Cannavo, G. M. Ghiggeri, E. Verrina, Y. Varadarajan, B. Raju, K.-H. Cho, J.-W. Park, K.-W. Yoon, T.-W. Kim, M. Kimmel, N. Braun, J. Latus, M. D. Alscher, D. Struijk, S. Van Esch, R. T. Krediet, T. Van den Beukel, T. Hoekstra, L. Tirapani, K. De Andrade Bastos, M. Bastos, F. Dekker, T. Yasuhisa, H. Kanai, K. Harada, Y. Kawai, H. Sugiyama, Y. Ito, K. Tsuruya, H. Yoshida, H. Maruyama, S. Goto, M. Nakayama, H. Nakamoto, H. Morinaga, S. Matsuo, H. Makino, M. C. DI Gioia, P. Gallar, N. Laso, I. Rodriguez, G. Cobo, A. Oliet, J. Hynostroza, J. C. Herrero, C. Mon, M. Ortiz, A. Vigil, T. Tomo, J. Portoles, S. Uta, A. M. Tato, P. Lopez-Sanchez, M. Rivera, R. Rodriguez-Pena, G. Del Peso, M. Ortega, C. Felipe, E. Tsampikaki, G. Aperis, A. Kaikis, C. Paliouras, N. Karvouniaris, M. Maragaki, P. Alivanis, B. Kortus-Gotze, T. Hoferhusch, J. Hoyer, F. Martino, M. Kaushik, M. P. Rodighiero, C. Creapldi, C. Ronco, A. Lacquaniti, V. Donato, M. R. Fazio, S. Lucisano, V. Cernaro, R. Lupica, M. Buemi, C. Aloisi, N. Bavbek Ruzgaresen, S. Secilmis, H. Yilmaz, A. Akcay, M. Duranay, N. Akalin, M. R. Altiparmak, S. Trabulus, A. S. Yalin, R. Ataman, K. Serdengecti, K. Schneider, B. Bator, B. Niko, F. Peter, C. Ulmer, L. Joerg, K. Martin, B. Dagmar, O. German, R. Fabian, D. Juergen, S. Stephan, A. Dominik, P. Fritz, B. Rettenmaier, S. Hirschburger, S. Segerer, D. Biegger, T. Lang, G. Ott, M. Habib, M. Korte, M. Hagen, F. Dor, M. Betjes, R. Zietse, C. Scharpf, T. I. Chang, D. H. Shin, D.-S. Han, H. Y. Choi, Y. K. Lee, B. S. Kim, T. H. Yoo, H. C. Park, H. Y. Lee, N. Horimoto, K. Tuji, S. Kitamura, R. Isshiki, M. Iwagami, D. Tsutsumi, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, H. Moriya, T. Ohtake, S. Hidaka, S. Kobayashi, C. Higuchi, Y. Tanihata, M. Ishii, H. Sugimoto, N. Sato, A. Kyono, T. Ogawa, H. Nishimura, K. Otsuka, J.-Y. Do, C. Du Halgouet, A. Latifa, V. Anne Sophie, D. Emmanuel, R. Christine, V. Francois, T. Grzelak, L. Czyzewska-Majchrzak, M. Kramkowska, H. Witmanowski, K. Czyzewska, K. Janda, M. Krzanowski, P. Dumnicka, W. Sulowicz, M. Rroji, S. Seferi, M. Barbullushi, E. Likaj, E. Petrela, N. Thereska, G. Cabiddu, E. Dessi, A. Arceri, P. Laura, E. Manca, M. Conti, R. Cao, A. Pani, C.-T. Liao, O. Vega Vega, A. Mendoza de la Garza, R. Correa-Rotter, A. Ueda, K. Nagai, M. Morimoto, A. Hirayama, S. Owada, Y. Tonozuka, C. Saito, K. Yamagata, A. Matsuda, Y. Tayama, M. Iwanaga, C. Noiri, M. Hatano, T. Kiba, K. Kanozawa, H. Katou, H. Hasegawa, T. Mitarai, S. Ros-Ruiz, L. Fuentes-Sanchez, C. Jironda-Gallegos, E. Gutierrez-Vilches, P. Garcia-Frias, D. Hernandez-Marrero, S. Lee, X. Lai, W. Chen, Z. Guo, M. Braide, V. Cristina, S. G. Popa, M. Maria, M. Eugen, P. DI Loreto, N. Spahia, L. O. Sanchez Macias, K. I. Lares Castellanos, J. A. Hernandez Pacheco, R. Correa Rotter, A. Pedro Ventura, S. Olivia, V. Joana, F. Francisco, C. Maria Joao, C. Antonio, A. S. Rodrigues, N. Atas, Y. Erten, K. Onec, S. Inal, S. Topal, A. Akyel, B. Celik, G. U. Okyay, Y. Tavil, M. Zeiler, T. Monteburini, R. M. Agostinelli, R. Marinelli, S. Santarelli, C. Yaylaci, G. Sahin, G. Guz, S. Sindel, A. Pinho, A. Malho Guedes, A. Fragoso, H. Carreira, I. Pinto, I. Bernardo, P. Leao, B. Kusnierz-Cabala, A. Krasniak, E. Chowaniec, B. Tabor-Ciepiela, K. Turkmen, O. Ozbek, M. Kayrak, C. Samur, I. Guler, H. Z. Tonbul, K. Rusai, R. Herzog, K. Kratochwill, L. Kuster, C. Aufricht, C.-M. Meier, D. Fliser, M. K. Schilling, M. Klingele, M. Fukasawa, M. Takeda, M. Kamiyama, Y. R. Song, H. J. Kim, S. G. Kim, J.-K. Kim, J. W. Noh, J. W. Yoon, and J.-R. Koo
- Subjects
Transplantation ,Nephrology - Published
- 2012
7. Diabetes - Experimental
- Author
-
K. P. Kang, J. E. Lee, A. S. Lee, Y. J. Jung, S. Lee, S. K. Park, W. Kim, M. Pokrywczynska, A. Jundzill, S. Krzyzanowska, M. Flisinski, A. Brymora, M. Bodnar, A. Deptula, A. Marszalek, J. Manitius, T. Drewa, T. Kloskowski, F. Grosjean, V. Esposito, M. Torreggiani, C. Esposito, F. Zheng, H. Vlassara, G. Striker, S. Michael, P. Viswanathan, R. Ganesh, M. Kimachi, S. Nishio, D. Nakazawa, Y. Ishikawa, T. Toyoyama, A. Satou, T. Nakagaki, S. Shibasaki, T. Atumi, V. Gattone, R. Peterson, K. Zimmerman, C. Mega, F. Reis, E. Teixeira de Lemos, H. Vala, R. Fernandes, J. Oliveira, F. Teixeira, A. Niculae, I.-A. Checherita, A. Ciocalteu, Y. Hamano, Y. Udagawa, Y. Ueda, O. Yokosuka, M. Ogawa, M. Satoh, K. Kidokoro, H. Nagasu, Y. Nishi, C. Ihoriya, H. Kadoya, T. Yada, K. M. Channon, T. Sasaki, N. Kashihara, J. R. Nyengaard, Z. Razga, S. Hartono, B. Knudsen, J. Grande, M. Watanabe, K. Ito, Y. Abe, S. Ogahara, H. Nakashima, T. Sato, T. Saito, Y. T. Shin, D. E. Choi, K.-R. Na, Y. K. Chang, S. S. Kim, K. W. Lee, C. Mace, S. Chugh, L. Clement, M. Tomochika, H. Seiji, M. Toshio, K. Tetsuya, K. Takao, J. C. Jaen, T. J. Sullivan, Z. Miao, N. Zhao, R. Berahovich, A. Krasinski, J. P. Powers, L. Ertl, T. J. Schall, S. Y. Han, H.-K. Sun, K. H. Han, H.-S. Kim, S.-H. Ahn, G. Kokeny, A. Gasparics, L. Fang, L. Rosivall, A. Sebe, N. F. Banki, A. Fekete, L. Wagner, A. Ver, P. Degrell, A. Prokai, R. George, A. Szabo, C. Baylis, A. Vannay, T. Tulassay, C. Chollet, A. Hus-Citharel, N. Caron, N. Bouby, K. Silva, R. Rampaso, R. Luiz, K. De Angelis, C. T. Mostarda, N. Abreu, M. C. Irigoyen, N. Schor, J. Montemor, E. M. S. Higa, Y. Nakayama, K. Fukami, N. Obara, R. Ando, Y. Kaida, S. Ueda, S.-I. Yamagishi, S. Okuda, Q. Qin, Z. Wang, J. Niu, W. Xu, Z. Qiao, W. Qi, Y. Gu, T. Zitman-Gal, E. Golan, J. Green, M. Pasmanik-Chor, V. Oron-Karni, J. Bernheim, S. Benchetrit, R.-N. Tang, M. Wu, M. Gao, H. Liu, X.-L. Zhang, and B. C. Liu
- Subjects
Transplantation ,Nephrology - Published
- 2012
8. P644 Factors and salvage surgery for treatment of pouch failure after restorative proctocolectomy for ulcerative colitis – a single-institution study
- Author
-
K. Tatsumi, H. Kuroki, Akira Sugita, R. Futatsuki, Kazutaka Koganei, and N. Obara
- Subjects
medicine.medical_specialty ,Proctocolectomy ,business.industry ,medicine.medical_treatment ,General surgery ,Gastroenterology ,General Medicine ,medicine.disease ,Ulcerative colitis ,medicine ,Salvage surgery ,Single institution ,Pouch ,business - Published
- 2017
9. S-band active phased array antenna with analog phase shifters using double-balanced mixers for mobile SATCOM vehicles
- Author
-
Shinichi Taira, M. Tanaka, Yoshiyuki Fujino, K. Sakauchi, A. Miura, T. Ojima, and N. Obara
- Subjects
Physics ,business.industry ,Phased array ,Electrical engineering ,Integrated circuit ,law.invention ,Amplitude ,Optics ,law ,Communications satellite ,Active antenna ,S band ,Electrical and Electronic Engineering ,business ,Phase shift module ,Phase-shift keying - Abstract
We propose an S-band active phased array antenna (APAA) with analog phase shifters (PSs) that use double-balanced mixers (DBMs). The quadrature phase shift keying modulator integrated circuits (ICs) used as the phase shifters can control both the amplitude and phase of the input signal continuously and independently by using the control voltages. The phase and amplitude errors during phase rotation were 0.5/spl deg/ rms (max=1.7/spl deg/) and 0.3 dB rms (max=0.7 dB), respectively. The range in which the amplitude could be linearly changed was 7 dB. The proposed antenna exhibited sufficient performance for mobile vehicles to handle satellite communications: beam-pointing resolution of 0.04/spl deg/, beam-pointing accuracy in the null pointing of 0.4/spl deg/ rms, and sidelobe suppression with an amplitude taper achieved by setting the amplitude of the PS using two DBMs. Comparison between the analog PS and a reflection-type four-bit digital PS showed that although the analog one is unsuitable for use in a passive PAA, it is suitable for use in an APAA.
- Published
- 2005
10. Hyperplasia of Schwann-Like Cells in the Bone Marrow of Patients with Myelodysplastic Syndromes
- Author
-
Takayasu Kato, H. Nishikii, Shigeru Chiba, T. Sakamoto, N. Obara, L. Cao-Sy, and M. Sakata-Yanagimoto
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,medicine.anatomical_structure ,Oncology ,business.industry ,Myelodysplastic syndromes ,Medicine ,Hematology ,Bone marrow ,Hyperplasia ,business ,medicine.disease - Published
- 2017
11. Risk Stratification by Self-Measured Home Blood Pressure across Categories of Conventional Blood Pressure: A Participant-Level Meta-Analysis
- Author
-
Asayama, K. Thijs, L. Brguljan-Hitij, J. Niiranen, T.J. Hozawa, A. Boggia, J. Aparicio, L.S. Hara, A. Johansson, J.K. Ohkubo, T. Tzourio, C. Stergiou, G.S. Sandoya, E. Tsuji, I. Jula, A.M. Imai, Y. Staessen, J.A. Asayama, K. Ohkubo, T. Kikuya, M. Inoue, R. Satoh, M. Hosaka, M. Utsugi, M.T. Hirose, T. Hara, A. Fukushima, N. Obara, T. Metoki, H. Imai, Y. Johansson, J. Reunanen, A. Jula, A. Ohmori-Matsuda, K. Kuriyama, S. Kakizaki, M. Hozawa, A. Tsuji, I. Mountokalakis, T. Kollias, A. Thomopoulou, G. Kalogeropoulos, P. Skeva, I. Nasothimiou, E. Pantazis, N. Baibas, N. Boggia, J. Sandoya, E. Staessen, J.A. Thijs, L. Cauwenberghs, N. Zhang, Z. Wei, F. Knez, J. Odili, A. Gu, Y. Liu, Y. Jin, Y. Jacobs, L. Kuznetzova, T.
- Abstract
Background:The Global Burden of Diseases Study 2010 reported that hypertension is worldwide the leading risk factor for cardiovascular disease, causing 9.4 million deaths annually. We examined to what extent self-measurement of home blood pressure (HBP) refines risk stratification across increasing categories of conventional blood pressure (CBP).Methods and Findings:This meta-analysis included 5,008 individuals randomly recruited from five populations (56.6% women; mean age, 57.1 y). All were not treated with antihypertensive drugs. In multivariable analyses, hazard ratios (HRs) associated with 10-mm Hg increases in systolic HBP were computed across CBP categories, using the following systolic/diastolic CBP thresholds (in mm Hg): optimal
- Published
- 2014
12. Communication and radio determination system using two geostationary satellites. II. Analysis of positioning accuracy
- Author
-
K. Kimura, N. Obara, H. Wakana, E. Morikawa, and S. Kozono
- Subjects
business.industry ,Computer science ,Benchmark (surveying) ,Geostationary orbit ,Global Positioning System ,Aerospace Engineering ,Satellite ,Mobile telephony ,Electrical and Electronic Engineering ,Ephemeris ,business ,Precise Point Positioning ,Remote sensing - Abstract
A new communication and radio determination system has been developed and experiments to evaluate the positioning accuracy of the system have been made. Theoretical estimates of the positioning accuracy and the results of experimental data analysis are presented. The relationship between the positioning error and the satellite ephemeris error while considering the dynamics of orbital motions are the main topics of discussion. Estimated improvements in positioning accuracy using benchmark stations are also described.
- Published
- 1996
13. Magnetic properties and exchange interactions in (GdxFe1-x)80Si12B8 amorphous alloys
- Author
-
N. Obara, H. Tange, S. Negami, T. Miyazaki, M. Goto, T. Kamimori, and Shunji Ishio
- Subjects
Magnetization ,Amorphous metal ,Materials science ,Condensed matter physics ,Magnetic moment ,Exchange interaction ,Mössbauer spectroscopy ,Analytical chemistry ,Curie temperature ,Magnetostriction ,Condensed Matter Physics ,Electronic, Optical and Magnetic Materials ,Amorphous solid - Abstract
Magnetization Curie temperature and magnetovolume effects of amorphous (Gd x Fe 1- x ) 80 Si 12 B 8 alloys (0.1 ⩽ x ⩽ 1.0) were investigated. Gd 80 Si 12 B 8 is an asperomagnet having the Curie temperature of 129 K. The large susceptibility of the asperomagnet enhances the forced volume magnetostriction for x more than 0.7, which reaches about 100 × 10 -10 Oe -1 at x = 1.0 and T = 30 K. The Mossbauer study revealed a decrease of the Fe magnetic moment with an increase of Gd content. Exchange interactions J FeFe and J FeGd evaluated by the fitting of σ - T curves are discussed and compared with those of crystalline GdFe compounds.
- Published
- 1993
14. ChemInform Abstract: Synthesis of Mesoionic Triazoline Nucleosides
- Author
-
Toshihiro Ikuma, N. Obara, Masataka Yokoyama, and Hideo Togo
- Subjects
Isothiouronium ,chemistry.chemical_compound ,chemistry ,Nucleic acid ,Mesoionic ,General Medicine ,Tetrabutylammonium fluoride ,Nucleoside ,Combinatorial chemistry - Abstract
A new type of protected mesoionic triazoline nucleoside was synthesized by the reaction of protected 1,2-dideoxy-hydrazino-D-ribose or 1-deoxy-hydrazino-D-ribose with isothiouronium compounds. The three compounds obtained 10a, 10f and 16a were deprotected with tetrabutylammonium fluoride. They showed no activity against HSV-1 virus.
- Published
- 2010
15. Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern
- Author
-
J, Inoue, Y, Ueno, Y, Wakui, H, Niitsuma, K, Fukushima, Y, Yamagiwa, M, Shiina, Y, Kondo, E, Kakazu, K, Tamai, N, Obara, T, Iwasaki, and T, Shimosegawa
- Subjects
Adult ,Male ,Hepatitis B virus ,Adolescent ,Genotype ,Adenine ,Organophosphonates ,RNA-Directed DNA Polymerase ,Kaplan-Meier Estimate ,Sequence Analysis, DNA ,Middle Aged ,Polymerase Chain Reaction ,Inhibitory Concentration 50 ,Young Adult ,Hepatitis B, Chronic ,Lamivudine ,DNA, Viral ,Drug Resistance, Viral ,Humans ,Point Mutation ,Reverse Transcriptase Inhibitors ,Drug Therapy, Combination ,Female ,Longitudinal Studies ,Aged - Abstract
To investigate the efficacy of long-term lamivudine (3TC) and adefovir dipivoxil (ADV) combination therapy in 3TC-resistant chronic hepatitis B virus (HBV) infected patients, we analysed 28 3TC-resistant patients treated with the combination therapy during 47 months (range, 9-75). At 12, 24, 36, and 48 months, the rates of virological response with undetectable HBV DNA (≤ 2.6 log copies/mL) were 56, 80, 86, and 92%, respectively. Among 17 hepatitis B e antigen (HBeAg)-positive patients, HBeAg disappeared in 24% at 12 months, 25% at 24 months, 62% at 36 months, and 88% at 48 months. When HBV genotypes were compared, patients with genotype B achieved virological response significantly more rapidly than those with genotype C (P=0.0496). One patient developed virological breakthrough after 54 months, and sequence analysis of HBV obtained from the patient was performed. An rtA200V mutation was present in the majority of HBV clones, in addition to the 3TC-resistant mutations of rtL180M+M204V. The rtN236T ADV-resistant mutation was observed in only 25% clones. In vitro analysis showed that the rtA200V mutation recovered the impaired replication capacity of the clone with the rtL180M+M204V mutations and induced resistance to ADV. Moreover, rtT184S and rtS202C, which are known entecavir-resistant mutations, emerged in some rtL180M+M204V clones without rtA200V or rtN236T. In conclusion, 3TC+ADV combination therapy was effective for most 3TC-resistant patients, especially with genotype B HBV, but the risk of emergence of multiple drug-resistant strains with long-term therapy should be considered. The mutation rtA200V with rtL180M+M204V may be sufficient for failure of 3TC+ADV therapy.
- Published
- 2010
16. Development of a Ka-band active phased array antenna for mobile SATCOM stations
- Author
-
S. Yamamoto, N. Obara, A. Miura, M. Tanaka, T. Takahashi, H. Wakana, and H. Saito
- Subjects
Beam waveguide antenna ,Engineering ,Directional antenna ,business.industry ,Phased array ,ComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKS ,Conformal antenna ,Electrical engineering ,Antenna rotator ,Collinear antenna array ,Electronic engineering ,Antenna (radio) ,business ,Omnidirectional antenna - Abstract
This paper describes a Ka-band active phased array antenna for mobile SATCOM stations. The active phased array is a fully electronic beam-scanning antenna system and is the most technically challenging component in the system development of the Japanese engineering test satellite, COMETS. The hardware components of the antenna, such as antenna element, LNA, and MMIC phase shifter, are described. Antenna tracking performances were measured and analyzed using a land mobile station and an aeronautical mobile station.
- Published
- 2005
17. Experiments of Communications & Radio Determination Spread Spectrum System Using Two Geostationary Satellites
- Author
-
K. Kimura, E. Morikawa, N. Obara, S. Kozono, Tetsushi Ikegami, M. Wakao, Y. Arakaki, and H. Wakana
- Subjects
Spread spectrum ,Base station ,Computer science ,business.industry ,Mobile antennas ,Geostationary orbit ,Satellite broadcasting ,Mobile telephony ,Telecommunications ,business - Published
- 2005
18. Slot array antenna system for COMETS advanced mobile satcom experiments
- Author
-
H. Saito, C. Ohuchi, Y. Hase, and N. Obara
- Subjects
Attitude control ,Control electronics ,Engineering ,Terminal (telecommunication) ,business.industry ,Satellite antennas ,Electrical engineering ,Geostationary orbit ,Communications satellite ,Electronic engineering ,Satellite ,Antenna (radio) ,business - Abstract
This paper describes the development of the slot array antenna system for the COMETS advanced mobile satellite communication experiments. COMETS is a Japanese engineering test satellite for Ka/Q-band mobile satellite communications, and is-scheduled for launch into geostationary orbit in the summer of 1997. The Communications Research Laboratory (CRL) has developed a compact mechanically steered antenna system for the COMETS mobile terminal. System performance with a high efficiency antenna and control electronics are discussed.
- Published
- 2002
19. Propagation characteristics of land mobile satellite communications in Japan using ETS-V satellite
- Author
-
H. Wakana, N. Obara, S. Yamamoto, and K. Tanaka
- Subjects
L band ,Phased array ,Communications satellite ,Electronic engineering ,Environmental science ,Satellite ,Fading ,Fade ,Signal ,Roof ,Remote sensing - Abstract
Using the Engineering Test Satellite-Five (ETS-V), L-band (1.5 GHz) propagation measurements of land mobile satellite communication channels on ordinary roads and expressways in Japan have been carried out, The total distance of the experiments is about 4,000 km. A continuous wave from the ETS-V, is received by a directional phased array antenna (Gain: 12 dBi) installed on the roof of a test van. The experimental results show that expressways and ordinary roads in rural and suburban areas are very suitable for land mobile satellite communication services. The paper describes the field experiments and statistical characteristics of the received signal levels, non-fade/fade duration distributions, fade depth and non-fade/fade state transition frequency. >
- Published
- 2002
20. Mobile/personal terminals for COMETS advanced mobile satellite communication experiment
- Author
-
C. Ohuchi, Y. Hase, T. Nishigaki, H. Saito, N. Obara, M. Takeuchi, M. Nishida, and H. Mineno
- Subjects
Terminal (telecommunication) ,Time-division multiplexing ,Computer science ,business.industry ,Mobile station ,Rain fall ,Key (cryptography) ,Communications satellite ,Mobile computing ,Telecommunications ,business ,Transponder - Abstract
The Communications Research Laboratory is now developing mobile and personal earth station terminals for an experimental advanced mobile satellite communication system using COMETS, which is scheduled for launch in 1997. The terminals under development are a briefcase-sized handy terminal for low bit-rate voice and a mobile terminal for voice and data. The system used the extremely high frequencies of the Ka-band (31/21 GHz) and the Q-band (47/44 GHz) and one-hop communication links between the terminals. Because of this, the terminal antennas, and countermeasures to rain fall attenuation will play key roles in the system hardware. An on-board regenerative transponder, the world's first SCPC/TDM type, will also be a key component of the system.
- Published
- 2002
21. Performance characteristics of a gas engine driven Stirling heat pump
- Author
-
J. Corey, N. Obara, Yuji Fukuyama, Ichiro Fujishima, Naotsugu Isshiki, Isao Satoh, Tomoyuki Morikawa, and Yagyu Sumio
- Subjects
Engineering ,Stirling engine ,business.industry ,Hybrid heat ,External combustion engine ,Mechanical engineering ,Coefficient of performance ,law.invention ,Cogeneration ,law ,Stirling cycle ,business ,Heat pump ,Heat engine - Abstract
This paper describes recent results in a project at KUBOTA to develop an efficient CFC-free multifunctional heat supply system. A heat pump in the system is a gas engine driven Stirling heat pump. The heat pump is mainly driven by engine shaft power and is partially assisted by thermal power from the engine exhaust heat. By proportioning two energy sources to match the heat balance of the driving engine, this heat-assisted Stirling heat pump can be supplied with the maximum share of the original energy fueling the engine and can be operated at the most efficient point. The authors have developed a system heat pump composed of 6 cylinders, the doubled E-3 prototype. This prototype uses helium gas as a working gas and is constructed as two sets of three-cylinder machines, each a combination of two Stirling sub-systems (one a power producer and one a heat pump). Design and performance simulations of the prototype are presented in conjunction with the driving engine characteristics. This heat supply system is expected to produce cooling and heating water at high COP. Developing the system will provide a CFC-free thermal utilization system technology that satisfies both wide heat demands and various fuel systems.
- Published
- 2002
22. [T-cell prolymphocytic leukemia with CD4+8+25+ phenotype in a patient presenting with venous thrombosis in the lower leg]
- Author
-
N, Obara, Y, Ohkoshi, H Y, Mukai, T, Komeno, Y, Hasegawa, H, Kojima, H, Ninomiya, and T, Nagasawa
- Subjects
Male ,Venous Thrombosis ,Leg ,Leukemia, T-Cell ,Phenotype ,CD4-CD8 Ratio ,Humans ,Receptors, Interleukin-2 ,Leukapheresis ,Middle Aged - Abstract
A 58-year-old man was referred to our hospital because of painful swelling in the left lower leg and leukocytosis in January 1999. Moderate hepatosplenomegaly but no lymph node swelling was observed. Marked leukocytosis (leukocytes 44.9 x 10(4)/microliter with 95% morphologically prolymphocytes) and thrombocytopenia were detected. The surface phenotype of the leukemia cells was CD1-2+3+5+7+4+8+25+. Magnetic resonance imaging revealed dilated veins in the left lower leg. An abnormal 47XY, +22 karyotype was detected in 1/20 cells. Tests for HTLV-I antibody were negative. A diagnosis of T-cell prolymphocytic leukemia (T-PLL) was made on the basis of data including cytochemical and electron microscopic findings. Although 2 courses of chemotherapy comprising vincristine, cyclophosphamide, and prednisolone improved the venous thrombosis in the leg, the leukemia cells were refractory to chemotherapy. To prevent the recurrence of venous thrombosis due to leukostasis, the patient underwent repeated leukapheresis. The leukocyte count was maintained at around 20.0 x 10(4)/microliter after total 7 courses of leukapheresis, one course of which comprised 7l of extracorporeal circulation. In addition to the rare presentation of venous thrombosis, the CD4+8+25+ phenotype observed in this case is rare in patients with T-PLL.
- Published
- 2000
23. The COMETS mobile torus reflector antenna
- Author
-
C. Ohuchi, Y. Hase, H. Saito, and N. Obara
- Subjects
Satellite mobile communication ,Geography ,Cassegrain antenna ,business.industry ,Electrical engineering ,Electronic engineering ,Communications satellite ,Satellite ,Torus ,Broadcasting ,Antenna (radio) ,business ,Periscope antenna - Abstract
Advanced mobile satellite communication experiments on the Communications and Broadcasting Engineering Test Satellite (COMETS) will be carried out mainly by the Communications Research Laboratory (CRL). A torus reflector antenna is being developed for a mobile millimeter-wave antenna of the COMETS. The CRL developed a prototype of the torus reflector antenna, and it seems that the prototype worked normally as expected from the calculated design. This was shown by the results of measuring its performance. The objectives of the experiments are to develop basic technology and to assess the feasibility of future mobile and personal satellite communications in the Ka-band (31/21 GHz) and millimeter-wave (47/44 GHz).
- Published
- 1997
24. Screening of allelopathic tree and ornamental plants around pond and lake against Cyanobacteria
- Author
-
Y. Fujii, K. Tsuda, M. Matsuyama, N. Obara, and N. Takamura
- Subjects
Cyanobacteria ,Tree (data structure) ,biology ,Ecology ,Botany ,Ornamental plant ,biology.organism_classification ,Allelopathy - Published
- 2005
25. Mobile and Personal Satellite Communications Experiments with Japan’s Experimental Satellite COMETS
- Author
-
N. Obara, M. Nishida, M. Takeuchi, C. Ohuchi, H. Mineno, and H. Saitok
- Subjects
Quasi-Zenith Satellite System ,Geography ,business.industry ,Mobile station ,Communications satellite ,Satellite ,Satellite navigation ,Satellite Internet access ,Mobile telephony ,Defense Satellite Communications System ,business ,Remote sensing - Abstract
In the early 21st century, the demand for fixed and mobile satellite communications for personal communications will increase rapidly. The Communications Research Laboratory plans to study an advanced mobile satellite communication system in the Ka-band and millimeter wave band by using the experimental satellite COMETS (Communications and Broadcasting Engineering test Satellite). The satellite has been developed in conjunction with NASDA and will be launched in the summer of 1997. This paper describes the outline of the COMETS project and the experimental system for the advanced mobile satellite communication mission.
- Published
- 1996
26. [Involvement of GABAergic and NMDA systems in drug-induced convulsions in mice]
- Author
-
N, Obara
- Subjects
Male ,Muscimol ,Mice, Inbred Strains ,Bicuculline ,Receptors, N-Methyl-D-Aspartate ,Mice ,Receptors, GABA ,Chloride Channels ,Seizures ,Phenobarbital ,Animals ,Picrotoxin ,Anticonvulsants ,Calcium Channels - Abstract
Intravenous (iv) pretreatment of muscimol, a GABAA receptor agonist, inhibited the convulsive effect of bicuculline but not that of picrotoxin, whereas phenobarbital, a Cl ion channel blocker, exhibited both effects. These results suggest that the bicuculline-induced convulsion may be due to Cl ion channel blockade secondary to the direct inhibition of GABAA receptors. CPP and MK-801, competitive and noncompetitive NMDA antagonists, respectively, inhibited both the bicuculline- and picrotoxin-induced convulsion, suggesting that these convulsive effects may also involve activation of the NMDA-Ca ion channel complex, which might link to the GABA-Cl ion channel system. Anticonvulsants phenytoin, carbamazepine and diazepam as well as phenobarbital inhibited the convulsive responses of bicuculline and picrotoxin. Therefore, the anticonvulsive effects of these drugs may involve an activation of the GABA-Cl ion channel function. On the other hand, neither the GABA agonist nor anticonvulsants affected NMDA-induced convulsion. These results also provide evidence that the convulsive effects of bicuculline and picrotoxin may be mediated by indirect activation of NMDA systems through their Cl ion channel-blocking action, whereas the convulsive effects of NMDA may involve the activation of NMDA-Ca ion channel function without the GABA-Cl ion channel activities.
- Published
- 1995
27. [Effects of dopamine receptor agonists and antagonists on cocaine-induced behaviors in rats]
- Author
-
N, Minematsu, I, Ushijima, N, Obara, Y, Mizuki, and M, Yamada
- Subjects
Male ,Behavior, Animal ,Dose-Response Relationship, Drug ,Receptors, Dopamine D1 ,Benzazepines ,Rats ,Rats, Sprague-Dawley ,Dopamine D2 Receptor Antagonists ,Cocaine ,Raclopride ,Salicylamides ,Animals ,Stereotyped Behavior ,Locomotion - Abstract
In this study, cocaine (5-20 mg/kg), an indirect dopamine agonist, increased locomotor activity and rearing accompanied with head circling and body shaking in a dose-dependent manner. A high dose of cocaine (40 mg/kg), meaning a toxic dose, slightly induced sniffing and licking. Both SCH23390, a D-1 receptor antagonist, and raclopride, a D-2 antagonist, inhibited all behaviors induced by cocaine, suggesting that the behavioral actions of cocaine may involve the activation of D-1 and D-2 receptors. Selective D-2 agonist quinpirole (0.1 and 1.0 mg/kg) inhibited hyperlocomotion induced by cocaine (20 mg/kg), but was replaced by the typical stereotyped behaviors such as sniffing at low dose (0.1 mg/kg), and licking and gnawing at high dose (1.0 mg/kg). SKF38393, a selective D-1 agonist, in combination of cocaine did not induce these stereotyped behaviors which resulted in synergistic interaction of D-1 and D-2 receptor stimulation. These results suggest that the indirect stimulation of postsynaptic D-2 receptors by cocaine (20 mg/kg) was insufficient to induce stereotyped behaviors. The actions of cocaine on dopamine D-1 receptors seem to be more potent than that on D-2 receptors.
- Published
- 1994
28. Progression & risk factors CKD 1-5 (1)
- Author
-
D. Bolignano, L. Zanoli, S. Rastelli, C. Marcantoni, G. Coppolino, G. Lucisano, C. Tamburino, E. Battaglia, P. Castellino, P. Presta, L. Pedrelli, F. Iiadis, A. Ntemka, T. Didangelos, A. Makedou, M. Divani, E. Moralidis, K. Makedou, A. Gotzamani-Psarakou, D. Grekas, L. Selistre, V. Souza, O. Domanova, P. Cochat, B. Ranchin, A. Varennes, L. Dubourg, A. Hadj-Aissa, D. Leonardis, F. Mallamaci, G. Enia, M. Postorino, G. Tripepi, C. Zoccali, null MAURO Working Group, C. Donadio, A. Kanaki, F. Caprio, E. Donadio, D. Tognotti, L. Olivieri, S. Eloot, E. Schepers, D. Barreto, F. Barreto, S. Liabeuf, W. Van Biesen, F. Verbeke, G. Glorieux, G. Choukroun, Z. Massy, R. Vanholder, A. Chaaban, F. Torab, S. Abouchacra, B. Bernieh, Q. Hussein, M. Osman, N. Gebran, Y. Kayyal, H. Al Omary, N. Nagelkerke, M. Horio, E. Imai, Y. Yasuda, S. Takahara, T. Watanabe, S. Matsuo, A. Fujimi, S. Ueda, K. Fukami, N. Obara, S. Okuda, P. Pecchini, M. Mieth, R. Mass, F. Malberti, R. Quinn, P. Ravani, H. Fujii, K. Kono, K. Nakai, S. Goto, M. Fukagawa, S. Nishi, M. Havrda, J. Granatova, Z. Vernerova, J. Vranova, L. Hornova, J. Zabka, I. Rychlik, K. Kratka, L. De Nicola, P. Zamboli, S. Mascia, M. Calabria, M. Grimaldi, G. Conte, R. Minutolo, G. Gluhovschi, M. Modilca, A. Kaycsa, S. Velciov, C. Gluhovschi, F. Bob, L. Petrica, G. Bozdog, S. Methven, J. Traynor, C. Deighan, D. O'Reilly, M. MacGregor, M. Szotowska, J. Chudek, M. Adamczak, A. Wiecek, I. Dudar, I. Shifris, O. Loboda, N. Yanagisawa, M. Ando, K. Tsuchiya, K. Nitta, R. Heguilen, A. Liste, M. Canteli, G. Muguerza, L. Cohen, M. Ortemberg, R. Hermes, A. Bernasconi, D. Galli, N. Miani, E. Staffolani, R. Nicolais, M. S. Borzacchi, C. Tozzo, S. Manca di Villahermosa, N. Di Daniele, K. Musial, D. Zwolinska, G. Loriga, C. Carru, A. Zinellu, A. Milia, A. E. Satta, I. Frolova, A. Kuryata, L. Koppe, E. Kalabacher, C. Pelletier, A. Geloen, D. Fouque, C. Soulage, S. Feriozzi, J. Torras, M. Cybulla, K. Nicholls, G. Sunder-Plassmann, and M. West
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Internal medicine ,medicine ,business - Published
- 2011
29. Performance of communications and radio determination system using two geostationary satellites
- Author
-
E. Morikawa, N. Obara, K. Kimura, M. Wakao, H. Wakana, and Y. Arakaki
- Subjects
Spread spectrum ,Geography ,Geostationary orbit ,Bit error rate ,Mobile communication systems ,Remote sensing - Published
- 1992
30. Fade characteristics for K-band land-mobile satellite channels in Tokyo measured using COMETS
- Author
-
N. Obara, A. Miura, S. Yamamoto, H. Wakana, and M. Ikeda
- Subjects
Beamwidth ,Azimuth ,Physics ,Satellite channel ,K band ,Elevation ,Electrical and Electronic Engineering ,Antenna (radio) ,Fade ,Remote sensing - Abstract
The K-band fade statistics in Tokyo were measured using an antenna (beamwidth of 19.5/spl deg/ in elevation and 6.5/spl deg/ in azimuth) at elevations ranging from 37 to 80/spl deg/. The results show that line-of sight communication is possible only /spl sim/33% of the distance at elevations
- Published
- 1999
31. Fade statistics measured by ETS-V in Japan for L-band land-mobile satellite communication systems
- Author
-
H. Wakana, S. Yamamoto, K. Tanaka, N. Yoshimura, and N. Obara
- Subjects
L band ,business.industry ,Rician fading ,Statistics ,Environmental science ,Tracking system ,Electrical and Electronic Engineering ,Fade ,Antenna (radio) ,business ,Satellite communication systems ,Remote sensing - Abstract
Fade statistics were measured along 4095 km of expressways using a 12 dBi gain antenna with an automatic tracking system. The results show that the line-of-sight statistics, which were available for more than 90% of total distance, can be described by a Rician distribution with Rician factors of 15 to 25 dB.
- Published
- 1996
32. Interleukin-6 and Tumor Necrosis Factor-α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.
- Author
-
S. Imagawa, Y. Yamaguchi, K. Ogawa, N. Obara, N. Suzuki, M. Yamamoto, and T. Nagasawa
- Subjects
SLEEP apnea syndromes ,PATIENTS ,VASCULAR endothelial growth factors ,GROWTH factors ,APNEA ,SLEEP disorders - Abstract
Background: In previous studies, significantly elevated levels of vascular endothelial growth factor (VEGF) have been reported in patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS). On the other hand, plasma tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) have been significantly higher in mild sleep apneics than in normal controls. However, this study included a small number of patients and milder cases of OSAHS. Objectives andMethods: To assess the involvement of IL-6 and TNF-α in VEGF increases in patients with severe OSAHS, serum levels of IL-6 and TNF-α were determined in patients with severe OSAHS (n = 110) and compared to those of controls (n = 45) using an enzyme-linked immunosorbent assay. Results: No significant increase in IL-6 or TNF-α was detected in the present study cohort. However, the body mass index was significantly correlated with the severity of the apnea-hypopnea index. Conclusions: These data suggest that the elevation in VEGF is not directly related to IL-6 or TNF-α levels. However, the question of whether VEGF is the cause or the result of OSAHS remains to be determined. Further studies are needed to clarify the role of IL-6 and TNF-α in the pathogenesis of OSAHS, in which obesity should be entered as an independent factor.Copyright © 2004 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
33. Synthesis of mesoionic triazoline nucleosides
- Author
-
Toshihiro Ikuma, N. Obara, Hideo Togo, and Masataka Yokoyama
- Subjects
Deoxyribonucleoside ,Isothiouronium ,chemistry.chemical_compound ,chemistry ,Herpesvirus hominis ,Mesoionic ,Organic chemistry ,Biological activity ,Ribonucleoside ,Tetrabutylammonium fluoride ,Nucleoside - Abstract
A new type of protected mesoionic triazoline nucleoside was synthesized by the reaction of protected 1,2-dideoxy-hydrazino-D-ribose or 1-deoxy-hydrazino-D-ribose with isothiouronium compounds. The three compounds obtained 10a, 10f and 16a were deprotected with tetrabutylammonium fluoride. They showed no activity against HSV-1 virus.
- Published
- 1990
34. Development of a Fine Aggregate Storage Silo to Stabilize the Surface Moisture
- Author
-
N. Obara, K. Hayasaka, and T. Taira
- Subjects
Aggregate (composite) ,Surface moisture ,Waste management ,Silo ,Environmental science ,General Materials Science ,Geotechnical engineering - Published
- 1989
35. Oceanographical Reserches of the Landlocked Water of Habu. Idu-Oosima Is., with Special Reference to the Favourable Character of Sea Water to the Colony of Purple Sulphur Bacteria
- Author
-
N. Obara
- Subjects
Oceanography ,Character (mathematics) ,chemistry ,Ecology ,Geography, Planning and Development ,chemistry.chemical_element ,Seawater ,Biology ,Landlocked country ,biology.organism_classification ,Sulfur ,Bacteria - Published
- 1941
36. Elevated Shoreline and Marrine Abrasion Platform found in the Vicinity of Simoda, Izu Province
- Author
-
N. Obara
- Subjects
Shore ,geography ,geography.geographical_feature_category ,Geography, Planning and Development ,Geomorphology ,Geology ,Abrasion (geology) - Published
- 1937
37. Morphology of the Tugaru Zyûniko Lake Group (2), Limnological Studies of the Tugaru Zyûniko Lake Group (1)
- Author
-
N. Obara, K. Koba, S. Yoshimura, and I. Nagatu
- Subjects
Hydrology ,Hydrology (agriculture) ,Morphology (linguistics) ,Hake ,Maximum depth ,Group (stratigraphy) ,Geography, Planning and Development ,Table (landform) ,Marine terrace ,Hectare ,Geology - Abstract
1. The Tugaru Zyuniko Lake Group is situated in the small valleys and small basins on the marine terraces at the southwestern corner of Aomori Prefecture. The lake group consists of 33 lakes, including small ponds. 2. The topography of the region is hilly. The water system is rather abnormal. The formation of the region is pearlitic tuff in which the lake basins have been excavated. 3. All the lakes are very small. There are only 12 lakes whose areas exceed 1 hectare. Even the largest lake, Oike has an area of only 9.1 hectare. These water surfaces total 46 hectares. 4. These lakes were sounded in the summer of 1934 from a portable rubber boat. They are very deep in spite of their small water surfaces. The maximum depth (27-3m) was found in Oike. The bottom configuration was fairely complex in some lakes. 5. Half of the lakes have no outlet. 6. The northern and southern lakes (Kosiguti-ike and the Oike hake Groups) and the middle lake group (ItobatakeRike and the Menkozaka-ike Lake Groups) are distinguished for their peculiar morphology and hydrology as seen in a table at following page. _??_
- Published
- 1934
38. Conditions govering the Salinity Fluctuations of the Upper Layer of Sea Water found through Daily Observations at Mikomoto Is., Idu Peninsula
- Author
-
N. Obara
- Subjects
Salinity ,geography ,Oceanography ,geography.geographical_feature_category ,Peninsula ,Geography, Planning and Development ,Seawater ,Layer (electronics) ,Geology - Published
- 1940
39. A Oceanographibal Study of the Sea Water of Simoda Bay, Idu yeninsula
- Author
-
N. Obara
- Subjects
Oceanography ,Geography, Planning and Development ,Environmental science ,Seawater ,Bay - Published
- 1940
40. Morphology of the Tugaru Zyûniko Lake Group (1), Limnological Studies of the Tugaru Zyûniko Lake Group (1)
- Author
-
K. Koba, I. Nagatu, N. Obara, and S. Yoshimura
- Subjects
Morphology (linguistics) ,Group (periodic table) ,Geography, Planning and Development ,Zoology ,Geology - Published
- 1934
41. Innervation of mouse molars during the early states of tooth germ development
- Author
-
N, Obara and M, Takeda
- Subjects
Mice ,Animals ,Tooth Germ ,Molar ,Tooth - Abstract
The topography of nerves and first molar tooth germs in 11-14-day embryos was studied using silver-impregnated serial sections. Nerve fibers growing toward the developing tooth germ became visible on the 12th day, while the first sign of molar tooth differentiation was found as a thickening of the oral epithelium in 11-day embryos. From the 12th to 13th day the nerve fibers spread, forming a plexus close to the base of the tooth bud, and on the 14th day some entered into the dental follicle of the tooth germ at the early cap stage. However, no nerve fiber was found growing into the dental papilla during the observation period. The observations showed that the earliest nerve fibers running toward the tooth forming area appeared after the histogenesis of the tooth germ started, and the timing and pattern of the innervation of the tooth germs revealed that tooth germs are a useful model for investigating the mechanism of nerve growth into developing peripheral organs.
- Published
- 1989
42. [Keratin filaments in the epithelial cells of circumvallate papillae]
- Author
-
M, Takeda, N, Obara, and Y, Suzuki
- Subjects
Actin Cytoskeleton ,Tongue ,Keratins ,Epithelium - Published
- 1988
43. [A case of transitional cell carcinoma occurring in the bladder and bilateral renal pelvis]
- Author
-
S, Numasato, K, Seino, K, Handa, Y, Sakuma, and N, Obara
- Subjects
Adult ,Male ,Neoplasms, Multiple Primary ,Carcinoma, Transitional Cell ,Urinary Bladder Neoplasms ,Urinary Bladder ,Humans ,Kidney Pelvis ,Neoplasm Recurrence, Local ,Ureter ,Nephrectomy ,Kidney Neoplasms - Abstract
A 41-year-old male patient underwent transurethral resection for multiple bladder tumors in January, 1979. The pathological examination of the specimen revealed non-invasive transitional cell carcinoma G 2. Thereafter, transurethral coagulation and vesical instillation of various antitumor agents were carried out several times for tumor recurrence during the following eight months. X-ray examination for evaluation of macrohematuria, 15 months following the above treatment, showed left renal pelvic tumor. Left total nephro-ureterectomy was performed in July, 1981. However, microhematuria and class V in urine cytology were continuously observed postoperatively. Right total nephroureterectomy, followed by surgery of the internal shunt, was performed in January, 1982, after diagnosis of renal pelvic tumor by further investigation. Under maintenance hemodialysis, vagotomy and pylorus plastic operation were performed for gastroduodenal bleeding after the above surgery. Total cystectomy and urethrectomy along with irradiation during and after surgery were performed for tumor recurrence in November, 1982 and July, 1983 respectively. Unfortunately, the patient died of multiple liver metastasis and gastro-intestinal bleeding in September, 1983. All the tumor specimens showed the same histological characteristics, i.e., transitional cell carcinoma G 3. Twenty six Japanese cases of epithelial tumors of the bilateral upper urinary tract are reviewed.
- Published
- 1984
44. Stimulation of pituitary cAMP accumulation by human pancreatic GH-releasing factor-(1-44)
- Author
-
N. Obara, M. D. Culler, T. Kenjo, and Akira Arimura
- Subjects
Pituitary growth hormone ,Male ,Pituitary gland ,medicine.medical_specialty ,Physiology ,Endocrinology, Diabetes and Metabolism ,Stimulation ,Peptide hormone ,Biology ,Growth Hormone-Releasing Hormone ,Pituitary Gland, Anterior ,Physiology (medical) ,Internal medicine ,1-Methyl-3-isobutylxanthine ,medicine ,Cyclic AMP ,Animals ,Humans ,Secretion ,Cells, Cultured ,Dose-Response Relationship, Drug ,Rats, Inbred Strains ,Pancreatic Hormones ,Peptide Fragments ,Stimulation, Chemical ,Rats ,medicine.anatomical_structure ,Endocrinology ,Bucladesine ,Cell culture ,Growth Hormone - Abstract
This study seeks to determine whether hpGRF-(1-44) stimulates pituitary growth hormone (GH) secretion and cAMP accumulation in a manner that is consistent with the concept of cAMP as an intracellular mediator of GH release. Addition of 10 nM hpGRF-(1-44) to rat anterior pituitary cell cultures stimulated a rapid elevation of intracellular cAMP that preceded or coincided with increases in GH and cAMP secretion. A dose-related increase in GH and cAMP release and in intracellular cAMP accumulation was observed in response to increasing concentrations of hpGRF-(1-44). Stimulation of cAMP accumulation and release, however, occurred over a hpGRF-(1-44) concentration range that was approximately one order of magnitude higher than required for dose-related GH release. Simultaneous addition of 0.05 nM hpGRF-(1-44) and 0.2, 0.5, or 1.0 mM 3-isobutyl-1-methylxanthine (MIX) to the cultures resulted in a significant potentiation of intracellular cAMP accumulation and release. Potentiation of GH release was not observed, however, probably due to attainment of maximal or near maximal GH release by MIX alone. The addition of increasing doses of exogenous N6-O2'-dibutyryladenosine 3',5'-cyclic monophosphate (DBcAMP) to cell cultures resulted in a dose-related increase in GH secretion. The results of this study are consistent with the concept of cAMP as a second messenger for hpGRF-(1-44) in stimulating GH release. Additionally, a novel method for cAMP extraction that utilizes trifluoroacetic acid is described.
- Published
- 1984
45. [Diagnosis and treatment of bladder tumor using a hematoporphyrin derivative and laser irradiation]
- Author
-
A, Tsuchiya, K, Imamura, Y, Mamiya, T, Aika, Y, Osumi, N, Obara, T, Matsumoto, T, Ohi, H, Kato, and Y, Hayata
- Subjects
Adult ,Male ,Carcinoma, Transitional Cell ,Hematoporphyrins ,Urinary Bladder Neoplasms ,Lasers ,Humans ,Female ,Laser Therapy ,Middle Aged ,Aged - Published
- 1983
46. Synthesis of novel nucleosides
- Author
-
M, Yokoyama, N, Yamada, T, Ikuma, N, Obara, H, Togo, and T, Imamoto
- Subjects
Nucleosides - Abstract
A new spironucleoside structural type and two new bicyclic nucleoside structural types were synthesized from the reaction of ribose nitrile oxide with dimethyl acetylenedicarboxylate. Next, a synthetic method for novel meso-ionic nucleoside structual type is presented.
- Published
- 1989
47. In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factor
- Author
-
C.M. Turkelson, N. Obara, Kate Groot, Jean Rivier, C.R. Thomas, Wylie Vale, Akira Arimura, M.D. Culler, and Mark G. Luciano
- Subjects
Male ,endocrine system ,medicine.medical_specialty ,Physiology ,Peptide ,In Vitro Techniques ,Growth Hormone-Releasing Hormone ,Biochemistry ,Cellular and Molecular Neuroscience ,Residue (chemistry) ,Basal (phylogenetics) ,Endocrinology ,Pancreatic tumor ,Internal medicine ,medicine ,Animals ,Humans ,ED50 ,Human Pancreatic Growth Hormone-Releasing Factor ,chemistry.chemical_classification ,Dose-Response Relationship, Drug ,medicine.disease ,Prolactin ,In vitro ,Hormones ,Peptide Fragments ,Rats ,Pancreatic Neoplasms ,chemistry ,Pituitary Hormone-Releasing Hormones ,hormones, hormone substitutes, and hormone antagonists - Abstract
The hypophysiotropic activities of a synthetic human pancreatic growth hormone releasing factor (hpGRF) with 40 residues was examined in vitro using rat pituitary halves. At concentrations from 10(-10) M to 10(-7) M the peptide stimulated GH release in a dose-dependent manner with the ED50 being 1.2 x 10(-9) M. The concentration of 10(-10) M hpGRF is comparable to the basal hypophyseal portal blood levels of other known hypothalamic hypophysiotropic hormones. However, GH release was enhanced three-fold by concentration as low as 10(-12) M, though no dose-response relationship was observed up to 10(-10) M. Thus, this peptide not only stimulates the release of GH in a dose-dependent manner, but at lower concentrations also maintains elevated GH levels. The release of ACTH, beta-endorphin, LH, and FSH was not affected by hpGRF at any of the concentrations tested. At hpGRF concentrations less than 10(-7) M, the release of TSH and PRL were unaffected. However, at 10(-6) M, TSH release was enhanced about 2.5 fold and prolactin release was elevated slightly.
- Published
- 1983
48. Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.
- Author
-
Sampei Z, Haraya K, Gan SW, Muraoka M, Hayasaka A, Fukuzawa T, Shida-Kawazoe M, Tsuboi Y, Gotoh A, Obara N, and Ueda Y
- Subjects
- Animals, Humans, Mice, Injections, Subcutaneous, Complement C5 antagonists & inhibitors, Complement C5 metabolism, Receptors, IgG metabolism, Histocompatibility Antigens Class I metabolism, Receptors, Fc metabolism, Antibodies, Monoclonal, Humanized administration & dosage, Antibodies, Monoclonal, Humanized therapeutic use, Hemoglobinuria, Paroxysmal drug therapy
- Abstract
The advent of recycling antibodies, leveraging pH-dependent antigen binding and optimized FcRn interaction, has advanced the field of antibody therapies, enabling extended durability and reduced dosages. Eculizumab (Soliris
® ) demonstrated the efficacy of C5 inhibitors for paroxysmal nocturnal hemoglobinuria (PNH), while its derivative, ravulizumab (Ultomiris® ), recognized as a recycling antibody, extended the dosing intervals. However, limitations including intravenous administration and inefficacy in patients with the R885H single-nucleotide polymorphism (SNP) in C5 could necessitate alternative solutions. Crovalimab (PiaSky® ), a next-generation recycling antibody, overcomes these challenges with innovative charge engineering, achieving the enhanced cellular uptake of C5-crovalimab complexes and targeting a unique C5 epitope, allowing for efficacy regardless of the R885H SNP. This study highlights crovalimab's distinctive molecular features, showing its eliminated binding to Fcγ receptors and C1q, alongside its optimized antigen binding characteristics. The impact of charge engineering was reconfirmed in mice, demonstrating faster C5 clearance than recycling antibodies. Notably, in the maintenance dosing regimen, crovalimab neutralizes approximately seven C5 molecules per antibody on average. Furthermore, its design also reduces the viscosity to facilitate high-concentration formulations suitable for subcutaneous delivery. Consequently, crovalimab offers a four-weekly subcutaneous injection regimen for PNH, marking a substantial improvement in treatment convenience and potentially transforming patients' quality of life.- Published
- 2024
- Full Text
- View/download PDF
49. Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings.
- Author
-
Obara N, Hatanaka S, Tsuji Y, and Higashi K
- Abstract
Idiopathic thrombocytopenic purpura (ITP), an autoimmune hematologic disorder characterized by severe platelet count reduction, can be treated with romiplostim. However, post-marketing safety and effectiveness data for romiplostim in Japan are scarce. This prospective, observational, post-marketing Specified Use-Results Survey evaluated the real-world safety and effectiveness of romiplostim for 2 years. All patients treated with romiplostim during the survey period were eligible. Of the 1622 patients in the safety analysis set, 94.08% (1526/1622) had chronic ITP. The mean single dose of romiplostim was stable after 12 weeks and remained < 6 μg/kg in approximately 70% of patients until 104 weeks. Within 2 years, 14.92% of patients discontinued romiplostim because of adverse events, while 6.47% discontinued because of suspected adverse drug reactions. In contrast, 14.00% of patients discontinued romiplostim because of symptom improvement. Before romiplostim initiation, platelet count was < 2.0 × 10
4 /µL in 60.54% of patients, and the mean platelet count was 2.84 ± 5.76 × 104 /µL. Platelet count was 9.19 ± 13.01 × 104 /µL after 4 weeks, and remained between 10.34 ± 10.72 and 12.38 ± 12.63 × 104 /µL from 8 to 104 weeks of treatment. No specific concerns were revealed regarding the safety and effectiveness of romiplostim in chronic ITP; the findings demonstrated a favorable risk-benefit balance for romiplostim in this population. Trial registration: UMIN000047864 ( www.umin.ac.jp/ctr )., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
50. Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
- Author
-
Röth A, He G, Tong H, Lin Z, Wang X, Chai-Adisaksopha C, Lee JH, Brodsky A, Hantaweepant C, Dumagay TE, Demichelis-Gómez R, Rojnuckarin P, Sun J, Höglund M, Jang JH, Gaya A, Silva F, Obara N, Kelly RJ, Beveridge L, Buatois S, Chebon S, Gentile B, Lundberg P, Sreckovic S, Nishimura JI, Risitano A, and Han B
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Hemolysis drug effects, Complement C5 antagonists & inhibitors, Aged, Hemoglobinuria, Paroxysmal drug therapy, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized adverse effects, Antibodies, Monoclonal, Humanized administration & dosage, Complement Inactivating Agents therapeutic use, Complement Inactivating Agents adverse effects
- Abstract
Crovalimab is a novel C5 complement inhibitor that enables rapid and sustained C5 inhibition with subcutaneous, low-volume self-administration every 4 weeks. COMMODORE 2 (NCT04434092) is a global, randomized, open-label, multicenter, phase 3 trial evaluating the non-inferiority of crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria not previously treated with C5 inhibition. C5 inhibitor-naive patients with lactate dehydrogenase (LDH) ≥2 × upper limit of normal (ULN) were randomized 2:1 to crovalimab or eculizumab. Co-primary efficacy endpoints were proportion of patients with hemolysis control (centrally assessed LDH ≤1.5 × ULN) and proportion with transfusion avoidance. Secondary efficacy endpoints were proportions of patients with breakthrough hemolysis, stabilized hemoglobin, and change in FACIT-Fatigue score. The primary treatment period was 24 weeks. Two hundred and four patients were randomized (135 crovalimab; 69 eculizumab). Crovalimab was non-inferior to eculizumab in the co-primary endpoints of hemolysis control (79.3% vs. 79.0%; odds ratio, 1.0 [95% CI, 0.6, 1.8]) and transfusion avoidance (65.7% vs. 68.1%; weighted difference, -2.8 [-15.7, 11.1]), and in the secondary efficacy endpoints of breakthrough hemolysis (10.4% vs. 14.5%; weighted difference, -3.9 [-14.8, 5.3]) and hemoglobin stabilization (63.4% vs. 60.9%; weighted difference, 2.2 [-11.4, 16.3]). A clinically meaningful improvement in FACIT-Fatigue score occurred in both arms. Complete terminal complement activity inhibition was generally maintained with crovalimab. The safety profiles of crovalimab and eculizumab were similar with no meningococcal infections. Most patients who switched from eculizumab to crovalimab after the primary treatment period preferred crovalimab. These data demonstrate the positive benefit-risk profile of crovalimab., (© 2024 The Author(s). American Journal of Hematology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.